We have been sold an antivaccine as a vaccine.
Official
Government and Pfizer statistics prove that the “old” Pfizer COVID
injection destroys the immune system at a rate greater than 1% per day.
Now,
the newly published study for Pfizer’s new bivalent COVID vaccine, to
combat both the original strain and Omicron, prove the old Covid-19
vaccine had a minus-44% negative efficacy after just 30 days.
The same study also, unfortunately, proves the destruction of the immune system is only going to get worse, not better.
According to Pfizer –
“Pfizer
and BioNTech’s bivalent vaccine contains 15-µg of mRNA encoding the
wild-type spike protein of SARS-CoV-2, which is present in the Original
Pfizer-BioNTech COVID-19 Vaccine, and 15-µg of mRNA encoding the spike
protein of the Omicron | BA.4/BA.5 subvariants.
“Because the
Omicron BA.4 and BA.5 subvariants contain identical spike protein amino
acid sequences, both can be targeted at once with a single mRNA strand.
“Apart
from the addition of the mRNA sequence of the Omicron BA.4/BA.5 spike
protein, all other components of the vaccine remain unchanged.” – https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-granted-fda-emergency-use-authorization
“One
month after administration, a booster dose of the Omicron-adapted
monovalent candidates (30 µg and 60 µg) increased neutralizing
(antibody) geometric mean titers (GMT) against Omicron BA.1 13.5 and
19.6-fold above pre-booster dose levels, while a booster dose of the
Omicron-adapted bivalent candidates conferred a 9.1 and 10.9-fold
increase in neutralizing (antibody) GMTs against Omicron BA.1.
“Both
Omicron-adapted vaccine candidates were well-tolerated in participants
who received one or the other Omicron-adapted vaccine” – https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-omicron-adapted-covid-19 .
From this information we shall now prove that the original vaccine shots destroy the immune system at a rate of 44% per month.
We have known that the vaccines in effect cause VAIDS. But we had not realised how quickly they do that until now…<<<Read More>>>....
Welcome to "A Light In The Darkness" - a realm that explores the mysterious and the occult; the paranormal and the supernatural; the unexplained and the controversial; and, not forgetting, of course, the conspiracy theories; including Artificial Intelligence; Chemtrails and Geo-engineering; 5G and EMR Hazards; The Net Zero lie ; Trans-Humanism and Trans-Genderism; The Covid-19 and mRNA vaccine issues; The Ukraine Deception ... and a whole lot more.
Search A Light In The Darkness
Showing posts with label Coronavirus Immunity?. Show all posts
Showing posts with label Coronavirus Immunity?. Show all posts
Monday, 19 September 2022
Thursday, 13 January 2022
The Imperial College finally acknowledges pre-existing immunity to COVID-19. What took it so long?
[SOTT]: T-cells from common cold coronaviruses can provide protection against COVID-19, an Imperial College London study has found. Reuters reports on the findings, which were published in Nature.
The study, which began in September 2020, looked at levels of cross-reactive T-cells generated by previous common colds in 52 household contacts of positive COVID-19 cases shortly after exposure, to see if they went on to develop infection.
It found that the 26 who did not develop infection had significantly higher levels of those T-cells than people who did get infected. Imperial did not say how long protection from the T-cells would last.
"We found that high levels of pre-existing T cells, created by the body when infected with other human coronaviruses like the common cold, can protect against COVID-19 infection," study author Dr Rhia Kundu said. The researchers suggest vaccines based on imitating the internal virus proteins that T-cells target may be more resilient to mutations and new variants as those proteins, unlike the spike protein targeted by the current vaccines, "mutate much less".
Cross-immunity to SARS-CoV-2 from other coronaviruses has been proposed since early on in the pandemic as an important element in reaching herd immunity and endemicity (for example, it was mentioned in this Scientist article from March 2020), and became a particular focus of interest in the autumn of 2020 as evidence of it accumulated (see here, here and here). It's good to have further confirmation of this from Imperial (and also recently from UCL), but it has to be said it's pretty late to the party, and it's not clear why a study which began in September 2020 during a public health emergency has taken 16 months to report, particularly when vaccines were brought to market in 10 months. The emphasis of the researchers is on the potential usefulness of the findings for developing new and more resilient vaccines, which contains a tacit admission that the existing vaccines are failing, but also leaves one wondering whether the research has only been published now that it is useful for making new pharmaceutical products. It might be added that the studies on the efficacy of generic off-label medicines against Covid are taking an awfully long time to report.
As Dr. Mike Yeadon explained in his October 2020 piece for the Daily Sceptic, "What SAGE Has Got Wrong", the assumption of a lack of pre-existing immunity and hence universal susceptibility was one of the great errors made by Government advisers throughout the pandemic and which led to an over-reaction that continues to this day. Now that Imperial researchers have acknowledged the existence of prior immunity, will Neil Ferguson's modelling team update its assumptions? ...<<<Read More>>>...
The study, which began in September 2020, looked at levels of cross-reactive T-cells generated by previous common colds in 52 household contacts of positive COVID-19 cases shortly after exposure, to see if they went on to develop infection.
It found that the 26 who did not develop infection had significantly higher levels of those T-cells than people who did get infected. Imperial did not say how long protection from the T-cells would last.
"We found that high levels of pre-existing T cells, created by the body when infected with other human coronaviruses like the common cold, can protect against COVID-19 infection," study author Dr Rhia Kundu said. The researchers suggest vaccines based on imitating the internal virus proteins that T-cells target may be more resilient to mutations and new variants as those proteins, unlike the spike protein targeted by the current vaccines, "mutate much less".
Cross-immunity to SARS-CoV-2 from other coronaviruses has been proposed since early on in the pandemic as an important element in reaching herd immunity and endemicity (for example, it was mentioned in this Scientist article from March 2020), and became a particular focus of interest in the autumn of 2020 as evidence of it accumulated (see here, here and here). It's good to have further confirmation of this from Imperial (and also recently from UCL), but it has to be said it's pretty late to the party, and it's not clear why a study which began in September 2020 during a public health emergency has taken 16 months to report, particularly when vaccines were brought to market in 10 months. The emphasis of the researchers is on the potential usefulness of the findings for developing new and more resilient vaccines, which contains a tacit admission that the existing vaccines are failing, but also leaves one wondering whether the research has only been published now that it is useful for making new pharmaceutical products. It might be added that the studies on the efficacy of generic off-label medicines against Covid are taking an awfully long time to report.
As Dr. Mike Yeadon explained in his October 2020 piece for the Daily Sceptic, "What SAGE Has Got Wrong", the assumption of a lack of pre-existing immunity and hence universal susceptibility was one of the great errors made by Government advisers throughout the pandemic and which led to an over-reaction that continues to this day. Now that Imperial researchers have acknowledged the existence of prior immunity, will Neil Ferguson's modelling team update its assumptions? ...<<<Read More>>>...
Friday, 14 August 2020
If you’ve ever had a cold, your immune system may already know how to fight COVID-19
[Natural News]: Since the common cold is a type of coronavirus, bearing many of the same features and attributes as the novel coronavirus, experts say that many people’s immune systems have already been “trained” to ward off infection without the need for pharmaceutical drugs or vaccines.
“Your immune system’s ‘memory’ T cells keep track of the viruses they have seen before,” researchers at LJI explain. “This immune cell memory gives the cells a head start in recognizing and fighting off repeat invaders.”
Published Aug. 4 in the journal Science, the LJI study breaks down the science behind how the immune system learns about diseases after being exposed to them. If a strong T cell response occurs in response to the common cold, it found, then the immune system is already primed to handle exposure to the Wuhan coronavirus (COVID-19).
“We have now proven that, in some people, pre-existing T cell memory against common cold coronaviruses can cross-recognize SARS-CoV-2, down to the exact molecular structures,” says Daniela Weiskopf, PhD, a research assistant professor at LJI who helped co-lead the new research alongside professor Alessandro Sette, Dr. Biol. Sci.
“This could help explain why some people show milder symptoms of disease while others get severely sick.”...<<<Read The Full Article Here>>>...
“Your immune system’s ‘memory’ T cells keep track of the viruses they have seen before,” researchers at LJI explain. “This immune cell memory gives the cells a head start in recognizing and fighting off repeat invaders.”
Published Aug. 4 in the journal Science, the LJI study breaks down the science behind how the immune system learns about diseases after being exposed to them. If a strong T cell response occurs in response to the common cold, it found, then the immune system is already primed to handle exposure to the Wuhan coronavirus (COVID-19).
“We have now proven that, in some people, pre-existing T cell memory against common cold coronaviruses can cross-recognize SARS-CoV-2, down to the exact molecular structures,” says Daniela Weiskopf, PhD, a research assistant professor at LJI who helped co-lead the new research alongside professor Alessandro Sette, Dr. Biol. Sci.
“This could help explain why some people show milder symptoms of disease while others get severely sick.”...<<<Read The Full Article Here>>>...
Monday, 15 June 2020
Most coronavirus patients develop “neutralizing antibodies” after recovery, but are they enough to head off another infection?
[Natural News]: A new study led by a team from The Rockefeller University in New York City suggests that most people infected with Wuhan coronavirus (COVID-19) develop antibodies after they recover.
But there’s a caveat: The team reveals that only some of these antibodies have the ability to neutralize the coronavirus. The immunological study looked at 149 people and found that while the antibodies they produced are able to latch onto the virus, only a few are capable of blocking it from infecting cells.
A total of 149 people who recovered from COVID-19 visited the Rockefeller Hospital to donate plasma, the part of blood that contains antibodies, as well as the immune B cells that produce them. Those who donated exhibited symptoms nearly 40 days before they donated plasma and had symptoms that lasted for an average of 12 days.
The researchers tested the neutralizing ability of the plasma samples using an antibody test that they developed. It involved mixing a pseudo version of the SARS-CoV-2 virus, the pathogen behind COVID-19, with the plasma samples and testing whether it can still infect human cells in vitro.
The team discovered that the neutralizing activity of a third of the plasma samples was below detectable levels. They interpreted this to mean that the owners of these samples were able to resolve the infection quickly, even before the antibody-producing cells got involved. Most of the samples, meanwhile, exhibited poor to modest neutralizing activity. Only 1 percent showed high neutralizing activity....<<<Read The Full Article Here>>>...
But there’s a caveat: The team reveals that only some of these antibodies have the ability to neutralize the coronavirus. The immunological study looked at 149 people and found that while the antibodies they produced are able to latch onto the virus, only a few are capable of blocking it from infecting cells.
A total of 149 people who recovered from COVID-19 visited the Rockefeller Hospital to donate plasma, the part of blood that contains antibodies, as well as the immune B cells that produce them. Those who donated exhibited symptoms nearly 40 days before they donated plasma and had symptoms that lasted for an average of 12 days.
The researchers tested the neutralizing ability of the plasma samples using an antibody test that they developed. It involved mixing a pseudo version of the SARS-CoV-2 virus, the pathogen behind COVID-19, with the plasma samples and testing whether it can still infect human cells in vitro.
The team discovered that the neutralizing activity of a third of the plasma samples was below detectable levels. They interpreted this to mean that the owners of these samples were able to resolve the infection quickly, even before the antibody-producing cells got involved. Most of the samples, meanwhile, exhibited poor to modest neutralizing activity. Only 1 percent showed high neutralizing activity....<<<Read The Full Article Here>>>...
Sunday, 10 May 2020
Is there really any such thing as “immunity” to the coronavirus?
[Natural News]: There has been a lot of talk lately about what it means to develop immunity to the Wuhan coronavirus (COVID-19). But is there really any such thing?
According to researchers from Columbia University in Manhattan, some people are developing multiple instances of the Wuhan coronavirus (COVID-19) which, if true, means that immunity to the virus is only temporary at best.
Beginning in the fall of 2016 and continuing on into 2018, scientists from the school began collecting nasal swabs from 191 children, teachers and emergency workers. Participants were asked to record every time they sneezed or had sore throats in order for those running the study to be able to create a map tracking common respiratory viruses and their symptoms, as well as how long people who recovered stayed immune to each one.
Four different coronaviruses, including HKU1, NL63, OC42, and C229E, were all included because these are common coronaviruses that circulate every year. You read that correctly: Coronaviruses are nothing new in society, and many people have them, often without even knowing it.
The new Wuhan coronavirus (COVID-19), or SARS-CoV-2, is said to be in the same family as these other coronaviruses, which would explain why most people develop only mild symptoms, or no symptoms at all. But some are reportedly developing much more serious symptoms and are even dying, which is prompting questions about how this novel virus behaves...<<<Read The Full Article Here>>>...
According to researchers from Columbia University in Manhattan, some people are developing multiple instances of the Wuhan coronavirus (COVID-19) which, if true, means that immunity to the virus is only temporary at best.
Beginning in the fall of 2016 and continuing on into 2018, scientists from the school began collecting nasal swabs from 191 children, teachers and emergency workers. Participants were asked to record every time they sneezed or had sore throats in order for those running the study to be able to create a map tracking common respiratory viruses and their symptoms, as well as how long people who recovered stayed immune to each one.
Four different coronaviruses, including HKU1, NL63, OC42, and C229E, were all included because these are common coronaviruses that circulate every year. You read that correctly: Coronaviruses are nothing new in society, and many people have them, often without even knowing it.
The new Wuhan coronavirus (COVID-19), or SARS-CoV-2, is said to be in the same family as these other coronaviruses, which would explain why most people develop only mild symptoms, or no symptoms at all. But some are reportedly developing much more serious symptoms and are even dying, which is prompting questions about how this novel virus behaves...<<<Read The Full Article Here>>>...
Subscribe to:
Posts (Atom)